abacavir[Title/Abstract] OR Ziagen[Title/Abstract] OR 1592U89[Title/Abstract]

Abacavir-induced hepatotoxicity: a report of two cases.

Soni S, Churchill DR, Gilleece Y.

AIDS. 2008 Nov 30;22(18):2557-8. No abstract available.

PMID: 19005287 [PubMed - in process]

Longitudinal evaluation of cardiovascular disease-associated biomarkers in relation to abacavir therapy.

Hammond E, McKinnon E, Mallal S, Nolan D.

AIDS. 2008 Nov 30;22(18):2540-3. No abstract available.

PMID: 19005279 [PubMed - in process]

Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?

Antiretroviral Therapy Cohort Collaboration (ART-CC), Mugavero MJ, May M, Harris R, Saag MS, Costagliola D, Egger M, Phillips A, Günthard HF, Dabis F, Hogg R, de Wolf F, Fatkenheuer G, Gill MJ, Justice A, D'Arminio Monforte A, Lampe F, Miró JM, Staszewski S, Sterne JA.

AIDS. 2008 Nov 30;22(18):2481-92.

PMID: 19005271 [PubMed - in process]

Pharmacogenetic determinants of immediate and delayed reactions of drug hypersensitivity.

Guéant JL, Guéant-Rodriguez RM, Gastin IA, Cornejo-García JA, Viola M, Barbaud A, Mertes PM, Blanca M, Romano A.

Curr Pharm Des. 2008;14(27):2770-7.

PMID: 18991696 [PubMed - in process]

HIV Pharmacogenetics in Clinical Practice: Recent Achievements and Future Challenges.

Tozzi V, Libertone R, Liuzzi G.

Curr HIV Res. 2008 Nov;6(6):544-54.

PMID: 18991620 [PubMed - in process]

Abacavir and cardiovascular risk in HIV-infected patients: does T lymphocyte hyperactivation exert a pathogenic role?

Marchetti G, Casana M, Tincati C, Bellistrì GM, Monforte A.

Clin Infect Dis. 2008 Dec 1;47(11):1495-6. No abstract available.

PMID: 18986270 [PubMed - in process]

Evaluation of a lymph node proliferation assay for its ability to detect pharmaceuticals with potential to cause immune-mediated drug reactions.

Weaver JL, Chapdelaine JM, Descotes J, Germolec D, Holsapple M, House R, Lebrec H, Meade J, Pieters R, Hastings KL, Dean JH.

J Immunotoxicol. 2005 Jan 1;2(1):11-20.

PMID: 18958655 [PubMed - in process]

FDA notifications. Abacavir package insert changes approved. Hypersensitivity, other issues addressed.

[No authors listed]

AIDS Alert. 2008 Sep;23(9):102-4. No abstract available.

PMID: 18939305 [PubMed - indexed for MEDLINE]

FDA notifications. Generic abacavir and lamivudine combo approved.

[No authors listed]

AIDS Alert. 2008 Oct;23(10):115. No abstract available.

PMID: 18935685 [PubMed - indexed for MEDLINE]

10:

Single-Measurement Therapeutic Drug Monitoring of the HIV/AIDS Drugs Abacavir, Zidovudine, Lamivudine, Efavirenz, Nevirapine, Lopinavir and Nelfinavir.

Donnerer J, Haas BJ, Kessler HH.

Pharmacology. 2008;82(4):287-292. Epub 2008 Oct 17.

PMID: 18931536 [PubMed - as supplied by publisher]

11:

The Medical and Economic Roles of Pipeline Pharmacogenetics: Alzheimer's Disease as a Model of Efficacy and HLA-B(*)5701 as a Model of Safety.

Roses AD.

Neuropsychopharmacology. 2008 Oct 15. [Epub ahead of print]

PMID: 18923406 [PubMed - as supplied by publisher]

12:

Current trends in screening across ethnicities for hypersensitivity to abacavir.

Rodriguez-Nóvoa S, Soriano V.

Pharmacogenomics. 2008 Oct;9(10):1531-41.

PMID: 18855539 [PubMed - in process]

13:

Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone.

Mira JA, López-Cortés LF, Barreiro P, Tural C, Torres-Tortosa M, de Los Santos Gil I, Martín-Rico P, Ríos-Villegas MJ, Hernández-Burruezo JJ, Merino D, López-Ruz MA, Rivero A, Muñoz L, González-Serrano M, Collado A, Macías J, Viciana P, Soriano V, Pineda JA.

J Antimicrob Chemother. 2008 Dec;62(6):1365-73. Epub 2008 Oct 13.

PMID: 18854330 [PubMed - in process]

14:

Impact of human immunodeficiency virus type 1 reverse transcriptase inhibitor drug resistance mutation interactions on phenotypic susceptibility.

Trivedi V, Von Lindern J, Montes-Walters M, Rojo DR, Shell EJ, Parkin N, O'Brien WA, Ferguson MR.

AIDS Res Hum Retroviruses. 2008 Oct;24(10):1291-300.

PMID: 18844463 [PubMed - indexed for MEDLINE]

15:

Effect of nucleoside and nucleotide reverse transcriptase inhibitors of HIV on endogenous nucleotide pools.

Vela JE, Miller MD, Rhodes GR, Ray AS.

Antivir Ther. 2008;13(6):789-97.

PMID: 18839780 [PubMed - indexed for MEDLINE]